scholarly journals Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulations

2015 ◽  
Vol 4 (5) ◽  
pp. 447-453 ◽  
Author(s):  
Axel S Merseburger ◽  
Thomas Björk ◽  
James Whitehouse ◽  
Davide Meani
2002 ◽  
Vol 37 (5) ◽  
pp. 485-487
Author(s):  
J. Aubrey Waddell ◽  
Patrick M. Garman ◽  
Dominic A. Solimando

The increasing complexity of cancer chemotherapy makes it mandatory that pharmacists be familiar with these highly toxic agents. This column reviews various issues related to the preparation, dispensing, and administration of cancer chemotherapy, both commercially available and investigational.


Sign in / Sign up

Export Citation Format

Share Document